Working with many rare forms of blood disorders, the Stanford Hematology Program brings together a multispecialty team of experts dedicated to treating leukemia as well as other benign and malignant hematologic disorders.
875 Blake Wilbur Drive
Palo Alto, CA 94304
Maps & Directions
875 Blake Wilbur Drive
Palo Alto, CA 94304
, BMT specialist
Offering state-of-the-art chemotherapy protocols for leukemia and other hematologic malignancies, as well as working seamlessly with Stanford's highly-acclaimed Blood and Marrow Transplant Program, the Hematology Program strives to assure the best possible outcome for patients. Our goal is to improve the survival and quality of life of patients, and Stanford hematologists were instrumental in the development of the National Comprehensive Cancer Network (NCCN) guidelines for the management of hematologic malignancies.
State-of-the-art surgical techniques to address metastatic tumors
Advanced minimally invasive surgery, including use of robotics to enhance complex procedures, minimize patient stays, and speed recovery times
Intraoperative radiation therapy (IORT), which delivers high-dose radiation directly to a patient's tumor site during surgery
New and investigational treatments, including PARP inhibitors, immunotherapies such as dendritic cell therapy, and ovarian cancer vaccines
Fertility-conserving surgery and advanced assisted reproductive technology to help maximize your childbearing options
Immunotherapy (also called biological therapy, biological response modifier therapy, or biotherapy) is designed to boost the body's immune system in order to fight cancer. The cells, antibodies, and organs of the immune system work to protect and defend the body against foreign invaders, such as bacteria or viruses. Doctors and researchers have found that the immune system might also be able to both determine the difference between healthy cells and cancer cells in the body, and to eliminate the cancer cells.
Robert Negrin, MD, Director of Stanford's Blood and Marrow Transplant program on why he left biochemistry to become a hematologist.
Through their laboratory investigation and clinical research, Stanford Hematology Program clinicians are identifying the biologic mechanisms responsible for the development of hematological disorders and developing more effective therapies to address these diseases. Additionally, our doctors are engaged a number of clinical trials through the Southwest Oncology Group and the Eastern Cooperative Oncology Group, as well as in Stanford-based studies.
Innovative research in clinical trials
Stanford has an extensive portfolio of clinical trials using novel therapies and investigational agents for all types of leukemia, multiple myeloma, and myelopfoliferative neoplasms.
Clinical trial participation
Doctors from the Division of Hematology are engaged a number of clinical trials through the Southwest Oncology Group and the Eastern Cooperative Oncology Group, as well as in Stanford-based studies. Some of our current clinical trials include:
Antibody therapy for chronic lymphocytic leukemia
Arsenic trioxide for promyelocytic leukemia
Anti-angiogenesis therapies (treatments that seek to prevent tumors from generating new blood supplies to nourish themselves)
Eligibility flowcharts map clinical trials to specific types of cancers to determine if a participant is eligible for the particular clinical trial. View all hematology eligibility flowcharts at the Stanford Cancer Institute.
Please fax the Medical Record Release Form to your new patient coordinator. The medical release form is an authorization form for external facilities to release medical records to Stanford Health Care (formerly Stanford Hospital & Clinics).
Stanford Health Care (formerly Stanford Hospital & Clinics) provides comprehensive services to refer and track patients, as well as provides the latest information and news for physicians and office staff. For help with all referral needs and questions visit Referring Physicians.
HOW TO REFER
Fax a referral form with supporting documentation to 650-320-9443.
Please note, though this form is from Stanford Health Care (formerly Stanford Hospital & Clinics), it is also used for all Cancer Center referrals.
Track your patients' progress and communicate with Stanford providers securely online.